Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
McKinsey
Moodys
Mallinckrodt
Harvard Business School

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Batefenterol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Batefenterol: Sponsors, patents, clinical trial progress

Batefenterol is an investigational drug.

There have been 4 clinical trials for Batefenterol. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Hammersmith Medicines Research, and [disabled in preview].

There are nine US patents protecting this investigational drug and one hundred and fifty-seven international patents.

Recent Clinical Trials for Batefenterol
TitleSponsorPhase
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy SubjectsHammersmith Medicines ResearchPhase 1
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy SubjectsGlaxoSmithKlinePhase 1
GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)Hammersmith Medicines ResearchPhase 1

See all Batefenterol clinical trials

Clinical Trial Summary for Batefenterol

Top disease conditions for Batefenterol
Top clinical trial sponsors for Batefenterol

See all Batefenterol clinical trials

US Patents for Batefenterol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Batefenterol   Start Trial Biphenyl derivatives Theravance, Inc. (South San Francisco, CA)   Start Trial
Batefenterol   Start Trial Crystalline form of a biphenyl compound Theravance, Inc. (South San Francisco, CA)   Start Trial
Batefenterol   Start Trial Biphenyl derivatives Theravance, Inc. (South San Francisco, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
McKinsey
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.